BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24145035)

  • 1. WD repeat protein WDR48 in complex with deubiquitinase USP12 suppresses Akt-dependent cell survival signaling by stabilizing PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1).
    Gangula NR; Maddika S
    J Biol Chem; 2013 Nov; 288(48):34545-54. PubMed ID: 24145035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
    Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
    Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PHLPPing through history: a decade in the life of PHLPP phosphatases.
    Grzechnik AT; Newton AC
    Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deubiquitinating enzyme Usp12 regulates the interaction between the androgen receptor and the Akt pathway.
    McClurg UL; Summerscales EE; Harle VJ; Gaughan L; Robson CN
    Oncotarget; 2014 Aug; 5(16):7081-92. PubMed ID: 25216524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells.
    Zhiqiang Z; Qinghui Y; Yongqiang Z; Jian Z; Xin Z; Haiying M; Yuepeng G
    J Cancer Res Clin Oncol; 2012 Jul; 138(7):1231-8. PubMed ID: 22426999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling.
    Warfel NA; Newton AC
    J Biol Chem; 2012 Feb; 287(6):3610-6. PubMed ID: 22144674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt.
    Warfel NA; Niederst M; Stevens MW; Brennan PM; Frame MC; Newton AC
    J Biol Chem; 2011 Jun; 286(22):19777-88. PubMed ID: 21454620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic suppression of PHLPP1 in human melanoma.
    Dong L; Jin L; Tseng HY; Wang CY; Wilmott JS; Yosufi B; Yan XG; Jiang CC; Scolyer RA; Zhang XD; Guo ST
    Oncogene; 2014 Sep; 33(39):4756-66. PubMed ID: 24121273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms.
    Hirano I; Nakamura S; Yokota D; Ono T; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K
    J Biol Chem; 2009 Aug; 284(33):22155-22165. PubMed ID: 19261608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells.
    Patterson SJ; Han JM; Garcia R; Assi K; Gao T; O'Neill A; Newton AC; Levings MK
    J Immunol; 2011 May; 186(10):5533-7. PubMed ID: 21498666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells.
    Suljagic M; Laurenti L; Tarnani M; Alam M; Malek SN; Efremov DG
    Leukemia; 2010 Dec; 24(12):2063-71. PubMed ID: 20861921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer.
    Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A
    J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.
    Bertacchini J; Mediani L; Beretti F; Guida M; Ghalali A; Brugnoli F; Bertagnolo V; Petricoin E; Poti F; Arioli J; Anselmi L; Bari A; McCubrey J; Martelli AM; Cocco L; Capitani S; Marmiroli S
    J Cell Physiol; 2019 Jul; 234(7):11188-11199. PubMed ID: 30565691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scribble-mediated membrane targeting of PHLPP1 is required for its negative regulation of Akt.
    Li X; Yang H; Liu J; Schmidt MD; Gao T
    EMBO Rep; 2011 Jun; 12(8):818-24. PubMed ID: 21701506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial Recruitment of UAF1-USP Complexes by a PHLPP1-E1 Chimeric Helicase Enhances Human Papillomavirus DNA Replication.
    Gagnon D; Lehoux M; Archambault J
    J Virol; 2015 Jun; 89(12):6227-39. PubMed ID: 25833051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turning off AKT: PHLPP as a drug target.
    Newton AC; Trotman LC
    Annu Rev Pharmacol Toxicol; 2014; 54():537-58. PubMed ID: 24392697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of the PH-domain and Leucine-rich Repeat Protein Phosphatase 1 (Phlpp1) Increases Fibroblast Growth Factor (Fgf) 18 Expression and Promotes Chondrocyte Proliferation.
    Bradley EW; Carpio LR; Newton AC; Westendorf JJ
    J Biol Chem; 2015 Jun; 290(26):16272-80. PubMed ID: 25953896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SGT1 regulates Akt signaling by promoting beta-TrCP-dependent PHLPP1 degradation in gastric cancer cells.
    Gao G; Kun T; Sheng Y; Qian M; Kong F; Liu X; Yu Z; Zhang H; Zhang Q; Gu J; Zhang X
    Mol Biol Rep; 2013 Apr; 40(4):2947-53. PubMed ID: 23440515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine/threonine kinase akt activation regulates the activity of retinal serine/threonine phosphatases, PHLPP and PHLPPL.
    Kanan Y; Matsumoto H; Song H; Sokolov M; Anderson RE; Rajala RV
    J Neurochem; 2010 Apr; 113(2):477-88. PubMed ID: 20089132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma.
    Molina JR; Agarwal NK; Morales FC; Hayashi Y; Aldape KD; Cote G; Georgescu MM
    Oncogene; 2012 Mar; 31(10):1264-74. PubMed ID: 21804599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.